These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 22617234

  • 1. Pathological classification of brain tumors.
    Pollo B.
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):103-11. PubMed ID: 22617234
    [Abstract] [Full Text] [Related]

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 3. Molecular diagnostics of gliomas: the clinical perspective.
    Tabatabai G, Stupp R, van den Bent MJ, Hegi ME, Tonn JC, Wick W, Weller M.
    Acta Neuropathol; 2010 Nov 01; 120(5):585-92. PubMed ID: 20862485
    [Abstract] [Full Text] [Related]

  • 4. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch T, Reifenberger G, Weller M, Loeffler M, von Deimling A.
    Acta Neuropathol; 2010 Dec 01; 120(6):707-18. PubMed ID: 21088844
    [Abstract] [Full Text] [Related]

  • 5. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
    Michotte A, Neyns B, Chaskis C, Sadones J, In 't Veld P.
    Acta Neurol Belg; 2004 Dec 01; 104(4):148-53. PubMed ID: 15742604
    [Abstract] [Full Text] [Related]

  • 6. [Histological and molecular classification of gliomas].
    Figarella-Branger D, Colin C, Coulibaly B, Quilichini B, Maues De Paula A, Fernandez C, Bouvier C.
    Rev Neurol (Paris); 2008 Dec 01; 164(6-7):505-15. PubMed ID: 18565348
    [Abstract] [Full Text] [Related]

  • 7. Input of molecular analysis in medical management of primary brain tumor patients.
    Idbaih A, Duran-Peña A, Bonnet C, Ducray F.
    Rev Neurol (Paris); 2015 Dec 01; 171(6-7):457-65. PubMed ID: 26026669
    [Abstract] [Full Text] [Related]

  • 8. Neuropathological diagnosis of brain tumours.
    Pollo B.
    Neurol Sci; 2011 Nov 01; 32 Suppl 2():S209-11. PubMed ID: 22009244
    [Abstract] [Full Text] [Related]

  • 9. [Update on the molecular biology of gliomas: towards a pathomolecular classification of gliomas].
    Idoate MA, Echeveste J.
    Rev Neurol; 2011 Nov 01; 44(4):217-24. PubMed ID: 17311212
    [Abstract] [Full Text] [Related]

  • 10. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
    Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A.
    Acta Neuropathol; 2009 Oct 01; 118(4):469-74. PubMed ID: 19554337
    [Abstract] [Full Text] [Related]

  • 11. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
    Raghunathan A, Olar A, Vogel H, Parker JR, Coventry SC, Debski R, Albarracin CT, Aldape KD, Cahill DP, Powell SZ, Fuller GN.
    Ann Diagn Pathol; 2012 Aug 01; 16(4):255-9. PubMed ID: 22445362
    [Abstract] [Full Text] [Related]

  • 12. [OMICS and biomarkers of glial tumors].
    Idbaih A.
    Rev Neurol (Paris); 2011 Oct 01; 167(10):691-8. PubMed ID: 21889780
    [Abstract] [Full Text] [Related]

  • 13. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
    Idbaih A, Omuro A, Ducray F, Hoang-Xuan K.
    Curr Opin Oncol; 2007 Nov 01; 19(6):606-11. PubMed ID: 17906460
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
    Marko NF, Prayson RA, Barnett GH, Weil RJ.
    Genomics; 2010 Jan 01; 95(1):16-24. PubMed ID: 19835948
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
    Ortega-Aznar A, Jimenez-Leon P, Martinez E, Romero-Vidal FJ.
    Rev Neurol; 2013 Feb 01; 56(3):161-70. PubMed ID: 23359078
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.